Invent Biotechnologies

Invent Biotechnologies is a private, commercial-stage company providing research tools and consumables for the proteomics and diagnostics research markets. Its core innovation is a proprietary spin column technology platform that streamlines complex sample preparation processes like protein extraction and subcellular fractionation, enabling faster, cleaner, and more reproducible results for academic and industrial researchers. The company operates a direct-to-researcher e-commerce model, selling globally, and appears to be in a revenue-generating phase with a portfolio of kits for various applications. Its strategic focus is on displacing traditional, labor-intensive methods in basic and translational research laboratories.

Proprietary spin column-based technology for rapid, simple, and high-purity protein extraction, cell fractionation, and organelle isolation using a standard tabletop centrifuge.

Operates in the highly competitive life science research consumables market, competing against giants like Thermo Fisher Scientific, Bio-Rad, and Merck Millipore, as well as numerous smaller specialty reagent companies. Its differentiation is based on a specific spin-column format that promises simplicity and reproducibility over traditional ultracentrifugation or multi-step protocols. Competitors offer alternative kits and technologies for similar applications, making continuous performance demonstration and customer support critical.